NCT05326048View on ClinicalTrials.gov

Defining an Immunological Signature Related to Lesion Location in Multiple Sclerosis

CompletedOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

March 9, 2022

Primary Completion Date

September 9, 2022

Study Completion Date

September 9, 2022

Conditions

Multiple Sclerosis

Interventions

OTHER

cytof analysis

cytof analysis of biological samples of CIS patients. Genomic analysis

Trial Locations (1)

35000

University hospital of Rennes, Rennes

All Listed Sponsors

lead

Rennes University Hospital

OTHER